The rapidly spreading monkeypox outbreak represents a global health emergency. As of 12 October 2022, 72,198 confirmed cases of monkeypox have been reported from 109 countries globally. Since the beginning of 2022, the continent of Arica has reported 5,227 cases and 137 deaths of monkeypox from eight endemic Africa Union Member States.
Africa CDC, African Union, and ASLM, which enabled them to increase the distribution of monkeypox virus test kits to African regions as part of Africa CDC’s continued commitment to addressing the developing emergency.
Bioperfectus was the first company to provide the Monkeypox Virus Real Time PCR Kits granted by CE Mark to the global market and has production capacity for raw materials and the development platform to rapidly produce specific primers and probes for the monkeypox virus PCR test. Bioperfectus has developed a suite of tests that detect the monkeypox virus and has extensive experience in the prevention and control of monkeypox disease worldwide.
Bioperfectus rapid reaction to emerging infectious diseases has been again proven in this monkeypox outbreak. In the future, we will continue to strengthen international collaboration on the surveillance of the monkeypox virus.